KKR Sinks Its Teeth Into Henry Schein

Henry Schein gets $250 million investment from private equity firm KKR
Private equity firm KKR & Co. Inc. has invested $250 million in Henry Schein Inc., Long Island’s largest publicly traded company by revenue, the Melville-based company announced Wednesday.
KKR Sinks Its Teeth Into Henry Schein With Additional Investment And Board Seats: Details
Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor disclosed a strategic investment of an additional $250 million from funds affiliated with KKR & Co.
KKR builds stake in Henry Schein, reaches deal to add board seats
Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the distributor of medical products said on Wednesday. Shares of Henry Schein were up more than 3% at $78.
KKR Takes Strategic Stake in Medical Supplier Henry Schein
KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s largest distributor of medical products to office-based dentists and doctors.
KKR Builds Stake in Henry Schein With $250M Investment
Henry Schein Inc., a leading healthcare solutions provider, has secured a $250 million investment from private equity powerhouse KKR, making KKR the company's largest non-index fund shareholder, according to a Wednesday announcement.
KKR builds stake in Henry Schein, agrees deal for board seats, WSJ reports
Private equity firm KKR has taken a large stake in Henry Schein and plans to work with the distributor of medical products to improve its operations, the Wall Street Journal reported on Wednesday citing people familiar with the matter.
Henry Schein announces KKR investment, prelim. Q4 sales (update)
Henry Schein (HSIC) stock in focus as KKR (KKR) builds stake and the company posts its preliminary Q4 2024 financials. Read more here.
Henry Schein gets a major private equity investment
Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and distributor.
Hold Rating Maintained for Henry Schein Amid Strategic Investment by KKR and Soft Operational Performance
Mizuho Securities analyst Steven Valiquette has maintained their neutral stance on HSIC stock, giving a Hold rating on January 23.Invest with
Henry Schein Announces Strategic Investment by KKR, Board Changes and Provides Preliminary Unaudited Financial Results and 2025 Financial Guidance
Henry Schein announces strategic investment by KKR, board changes, and provides preliminary unaudited financial results and 2025 financial guidance.
Hold Rating on Henry Schein Amid KKR Investment and Market Uncertainties
In a report released on January 29, Michael Cherny from Leerink Partners reiterated a Hold rating on Henry Schein (HSIC – Research Report), ...
KKR Builds Stake in Henry Schein, Reaches Deal for Board Seats, WSJ Reports
(Reuters) - Private-equity firm KKR has taken a large stake in Henry Schein and plans to work with the distributor of ...